Jean-François Gélinas, University of Ottawa

Research

Gene Therapy Respiratory Disease Surfactant B Deficiency Viral Vector

Latest funding

Novel gene therapy platform for monogenetic lung diseases
CIHR · 2023 · Principal investigator

All 1 grants and awards

Novel gene therapy platform for monogenetic lung diseases

Principal investigatorCIHR2023Op. Grant :Bringing Rare Disease Gene Therapies to Clinical Trial Readiness- LOI

Principal investigators: Thebaud, Bernard; Gélinas, Jean-François; Wootton, Sarah

Keywords: Gene Therapy; Respiratory Disease; Surfactant B Deficiency; Viral Vector

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Gene Therapy Dear Professor Gélinas, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on gene therapy connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Novel gene therapy platform for monogenetic lung diseases" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]